Title : International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH
link : International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH
International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH
Clinical Care Options
Program Overview
2018 Annual Meeting of the European Association for the Study of the Liver*
April 11-15, 2018 | Paris, France
Program Overview
2018 Annual Meeting of the European Association for the Study of the Liver*
April 11-15, 2018 | Paris, France
Review Capsules Summaries, download slides, and listen to audio commentary from expert-led Webinars covering critical studies on viral hepatitis and NAFLD/NASH from Paris.
Link: https://www.clinicaloptions.com/Hepatitis/Conference%20Coverage/Paris%202018.aspx
Free registration required
Viral Hepatitis
Capsule Summaries (6)
Addition of RBV Associated With Increased Efficacy of 12 Weeks Sofosbuvir/Velpatasvir in Patients With Genotype 3 HCV Infection and Compensated CirrhosisCapsule Summaries (6)
Retreatment of Patients Who Failed Glecaprevir/Pibrentasvir Treatment for Hepatitis C Virus Infection
A Phase 3b, Open-Label, Randomized, Pragmatic Study of Glecaprevir/Pibrentasvir +/- Ribavirin (RBV) for HCV Genotype 1 Subjects Who Previously Failed an NS5A Inhibitor + Sofosbuvir (SOF) Therapy
8 Weeks Sofosbuvir/Velpatasvir in Genotype 3 Patients With Significant Fibrosis: Highly Effective Amongst an OST Cohort (Coming soon)
Safety and Efficacy at 1 Year After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic HBV Patients With Risk Factors for TDF Use
High Efficacy and Safety of Grazoprevir and Elbasvir for 8 Weeks in Treatment-Naive, Nonsevere Fibrosis HCV GT1B-Infected Patients: Interim Results of the STREAGER Study
Low-Moderate Alcohol Use Is Associated With a Lower Prevalence of Nonalcoholic Fatty Liver Disease in Hispanics/Latinos Living in the US: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Substantial Comorbidities and Rising Economic Burden In Real-World Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients With Compensated Cirrhosis (CC): A Large German Claims Database Study (Coming soon)
Nonalcoholic Fatty Liver Disease and Relative Risk of Incident Steatohepatitis, Cirrhosis and Hepatocellular Carcinoma Events in 4 European Primary Care Databases
Prevalence and Stratification of NAFLD/NASH in a UK and US Cohort Using Noninvasive Multiparametric MRI
Begin here.......
Thus Article International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH
That's an article International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH with the link address https://theleknews.blogspot.com/2018/04/international-liver-congress-2018_20.html
0 Response to "International Liver Congress 2018 - Webinars covering critical studies on viral hepatitis and NAFLD/NASH"
Post a Comment